Aclarion, Inc. (ACON)
NASDAQ: ACON · Real-Time Price · USD
3.040
-0.080 (-2.56%)
At close: Jun 22, 2026, 4:00 PM EDT
3.250
+0.210 (6.90%)
After-hours: Jun 22, 2026, 6:02 PM EDT
Aclarion Revenue
Aclarion had revenue of $21.14K in the quarter ending March 31, 2026, with 11.32% growth. This brings the company's revenue in the last twelve months to $77.88K, up 42.63% year-over-year. In the year 2025, Aclarion had annual revenue of $75.73K with 65.62% growth.
Revenue (ttm)
$77.88K
Revenue Growth
+42.63%
P/S Ratio
96.11
Revenue / Employee
$7,080
Employees
11
Market Cap
7.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75.73K | 30.01K | 65.62% |
| Dec 31, 2024 | 45.72K | -29.68K | -39.36% |
| Dec 31, 2023 | 75.40K | 14.96K | 24.75% |
| Dec 31, 2022 | 60.44K | 152.00 | 0.25% |
| Dec 31, 2021 | 60.29K | 11.64K | 23.93% |
| Dec 31, 2020 | 48.65K | 21.76K | 80.88% |
| Dec 31, 2019 | 26.90K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Definitive Healthcare | 238.26M |
| CareCloud | 124.14M |
| OptimizeRx | 107.35M |
| DarioHealth | 21.19M |
| Healthcare Triangle | 20.04M |
| VSee Health | 14.46M |
| Mobile-health Network Solutions | 7.32M |
| OneMedNet | 1.32M |
ACON News
- 5 days ago - Aclarion Transcript: Planet MicroCap Las Vegas 2026 - Transcripts
- 13 days ago - Aclarion partners with PRIA Healthcare to expand access to Nociscan - TheFly
- 14 days ago - Aclarion rejects Echo Lake acquisition proposal - TheFly
- 25 days ago - Aclarion to ‘carefully review and evaluate’ Echo Lake’s proposal - TheFly
- 25 days ago - Echo Lake offers to acquire Aclarion for $4 per share in cash - TheFly
- 25 days ago - Echo Lake Capital Offers To Acquire Aclarion Inc. - Accesswire
- 5 weeks ago - Aclarion Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Aclarion enters second commercial agreement with Weill Cornell Medicine - TheFly